Portage Biotech Statistics
Total Valuation
Portage Biotech has a market cap or net worth of $16.77 million. The enterprise value is $14.51 million.
Important Dates
The next estimated earnings date is Tuesday, September 9, 2025, before market open.
| Earnings Date | Sep 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Portage Biotech has 2.28 million shares outstanding. The number of shares has increased by 22.21% in one year.
| Current Share Class | 2.28M |
| Shares Outstanding | 2.28M |
| Shares Change (YoY) | +22.21% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 34.59% |
| Owned by Institutions (%) | 4.47% |
| Float | 829,850 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.02
| Current Ratio | 2.02 |
| Quick Ratio | 1.53 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,472.67 |
Financial Efficiency
Return on equity (ROE) is -541.81% and return on invested capital (ROIC) is -363.77%.
| Return on Equity (ROE) | -541.81% |
| Return on Assets (ROA) | -92.69% |
| Return on Invested Capital (ROIC) | -363.77% |
| Return on Capital Employed (ROCE) | -659.38% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.69M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.64% in the last 52 weeks. The beta is 0.60, so Portage Biotech's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +14.64% |
| 50-Day Moving Average | 6.73 |
| 200-Day Moving Average | 6.05 |
| Relative Strength Index (RSI) | 46.60 |
| Average Volume (20 Days) | 50,833 |
Short Selling Information
The latest short interest is 36,165, so 1.59% of the outstanding shares have been sold short.
| Short Interest | 36,165 |
| Short Previous Month | 37,398 |
| Short % of Shares Out | 1.59% |
| Short % of Float | 4.36% |
| Short Ratio (days to cover) | 0.88 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.42M |
| Pretax Income | -170.41M |
| Net Income | -6.77M |
| EBITDA | -7.38M |
| EBIT | -7.42M |
| Earnings Per Share (EPS) | -$5.72 |
Full Income StatementBalance Sheet
The company has $1.67 million in cash and n/a in debt, giving a net cash position of $1.67 million or $0.73 per share.
| Cash & Cash Equivalents | 1.67M |
| Total Debt | n/a |
| Net Cash | 1.67M |
| Net Cash Per Share | $0.73 |
| Equity (Book Value) | -827,000 |
| Book Value Per Share | -0.07 |
| Working Capital | 1.13M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.46M |
| Capital Expenditures | n/a |
| Free Cash Flow | -5.46M |
| FCF Per Share | -$2.40 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
